Apimeds Pharmaceuticals US, Inc. (APUS) — Working Capital to Net Assets Ratio
Apimeds Pharmaceuticals US, Inc. (APUS) has a Working Capital to Net Assets ratio of 98.0% as of September 2025. Working capital of $8.00 Million (current assets of $9.09 Million minus current liabilities of $1.09 Million) is measured against net assets of $8.16 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Apimeds Pharmaceuticals US, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apimeds Pharmaceuticals US, Inc. Working Capital to Net Assets (2021–2024)
This chart shows how Apimeds Pharmaceuticals US, Inc.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 98.0%, reflecting working capital of $8.00 Million against net assets of $8.16 Million USD. See net asset quality index of Apimeds Pharmaceuticals US, Inc. to measure how much of total assets are equity-financed.
Annual Working Capital to Net Assets for Apimeds Pharmaceuticals US, Inc. (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apimeds Pharmaceuticals US, Inc. from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Apimeds Pharmaceuticals US, Inc. stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 74.5% | $-1.01 Million | $-1.36 Million | $13.06K | $1.02 Million | ▼ -862.9 pp |
| 2023 | 937.4% | $298.76K | $31.87K | $422.08K | $123.31K | ▲ +893.5 pp |
| 2022 | 43.9% | $-313.61K | $-713.61K | $6.17K | $319.78K | ▲ +111.7 pp |
| 2021 | -67.7% | $161.52K | $-238.48K | $172.17K | $10.65K | — |